Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: A qualitative insight into the perspectives of surgeons and medical oncologists

Journal of Geriatric Oncology

Volumn 6, Issue 3, 2015, Pages 219-224

  van Erning, Felice N ^a,b   Janssen Heijnen, Maryska L G ^c,d   Creemers, Geert Jan ^e   Pruijt, Hans F M ^f   Maas, Huub A A M ^g   Lemmens, Valery E P P ^a,b  

^a Netherlands Comprehensive Cancer Organisation (IKNL)   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VIECURI MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f JEROEN BOSCH HOSPITAL   (Netherlands)

^g Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Adjuvant chemotherapy; Chemotherapy related toxicity; Colon cancer; Elderly; Geriatrics; Oncology; Referral; Treatment related decision making

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; COLON CANCER; COMMUNITY HOSPITAL; COMORBIDITY; CONSULTATION; DRUG TOLERABILITY; FEMALE; GERIATRIC PATIENT; GERIATRICIAN; HEALTH STATUS; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL ONCOLOGIST; MEDICAL SPECIALIST; NEUROPATHY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SURGEON; TREATMENT REFUSAL; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLONIC NEOPLASMS; DECISION MAKING; GERIATRICS; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; ONCOLOGY; PATIENT REFERRAL; UTILIZATION; VERY ELDERLY;

ADULT; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DECISION MAKING; FEMALE; GERIATRICS; HOSPITALS, COMMUNITY; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NETHERLANDS; REFERRAL AND CONSULTATION; SURGEONS; SURVEYS AND QUESTIONNAIRES;

EID: 84930478697     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2015.02.001     Document Type: Article

References (12)

1. van Steenbergen L.N., Lemmens V.E., Rutten H.J., Wymenga A.N., Nortier J.W., Janssen-Heijnen M.L. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands. Ann. Oncol. 2012, 23:2805-2811.
2. van Erning F.N., Bernards N., Creemers G.J., Vreugdenhil A., Lensen C.J., Lemmens V.E. Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital. Acta Oncol. (Stockh.) 2014, 53:975-980. 10.3109/0284186X.2013.878470.
3. DSCA Annual report [cited 20-01-2015]; Available from:. http://www.clinicalaudit.nl/jaarrapportage/2013/#dica_rapportages_dsc.
4. El Shayeb M., Scarfe A., Yasui Y., Winget M. Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review. BMC Res. Notes 2012, 5:269. 10.1186/1756-0500-5-269.
5. Hoeben K.W., van Steenbergen L.N., van de Wouw A.J., Rutten H.J., van Spronsen D.J., Janssen-Heijnen M.L. Treatment and complications in elderly stage III colon cancer patients in the Netherlands. Ann. Oncol. 2013, 24:974-979. 10.1093/annonc/mds576.
6. Luo R., Giordano S.H., Zhang D.D., Freeman J., Goodwin J.S. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer 2007, 109:975-982. 10.1002/cncr.22462.
7. McCleary N.J., Dotan E., Browner I. Refining the chemotherapy approach for older patients with colon cancer. J. Clin. Oncol. 2014, 10.1200/JCO.2014.55.1960.
8. Papamichael D., Audisio R.A., Glimelius B., de Gramont A., Glynne-Jones R., Haller D., et al. Treatment of colorectal cancer in older patients. International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann. Oncol. 2014, 10.1093/annonc/mdu253.
9. Kenis C., Bron D., Libert Y., Decoster L., Van Puyvelde K., Scalliet P., et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann. Oncol. 2013, 24:1306-1312. 10.1093/annonc/mds619.
10. Decoster L., Kenis C., Van Puyvelde K., Flamaing J., Conings G., De Greve J., et al. The influence of clinical assessment (including age) and geriatric assessment on treatment decisions in older patients with cance 2013, 4:235-241. 10.1016/j.jgo.2013.04.010.
11. Mols F., Beijers T., Vreugdenhil G., van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 2014, 22:2261-2269. 10.1007/s00520-014-2255-7.
12. Mols F., Beijers T., Lemmens V., van den Hurk C.J., Vreugdenhil G., van de Poll-Franse L.V. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J. Clin. Oncol. 2013, 31:2699-2707. 10.1200/JCO.2013.49.1514.